252 related articles for article (PubMed ID: 19620134)
21. Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.
Di Giambenedetto S; Zazzi M; Corsi P; Gonnelli A; Di Pietro M; Giacometti A; Almi P; Trezzi M; Boeri E; Gianotti N; Menzo S; Del Gobbo R; Francisci D; Nerli A; Galli L; De Luca A;
Antivir Ther; 2009; 14(3):359-69. PubMed ID: 19474470
[TBL] [Abstract][Full Text] [Related]
22. Advantages of predicted phenotypes and statistical learning models in inferring virological response to antiretroviral therapy from HIV genotype.
Altmann A; Sing T; Vermeiren H; Winters B; Van Craenenbroeck E; Van der Borght K; Rhee SY; Shafer RW; Schülter E; Kaiser R; Peres Y; Sönnerborg A; Fessel WJ; Incardona F; Zazzi M; Bacheler L; Van Vlijmen H; Lengauer T
Antivir Ther; 2009; 14(2):273-83. PubMed ID: 19430102
[TBL] [Abstract][Full Text] [Related]
23. Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time.
Frentz D; Boucher CA; Assel M; De Luca A; Fabbiani M; Incardona F; Libin P; Manca N; Müller V; O Nualláin B; Paredes R; Prosperi M; Quiros-Roldan E; Ruiz L; Sloot PM; Torti C; Vandamme AM; Van Laethem K; Zazzi M; van de Vijver DA
PLoS One; 2010 Jul; 5(7):e11505. PubMed ID: 20634893
[TBL] [Abstract][Full Text] [Related]
24. Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.
Cozzi-Lepri A; Phillips AN; Clotet B; Mocroft A; Ruiz L; Kirk O; Lazzarin A; Wiercinska-Drapalo A; Karlsson A; Lundgren JD;
AIDS; 2008 Oct; 22(16):2187-98. PubMed ID: 18832882
[TBL] [Abstract][Full Text] [Related]
25. Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response.
Vercauteren J; Beheydt G; Prosperi M; Libin P; Imbrechts S; Camacho R; Clotet B; De Luca A; Grossman Z; Kaiser R; Sönnerborg A; Torti C; Van Wijngaerden E; Schmit JC; Zazzi M; Geretti AM; Vandamme AM; Van Laethem K
PLoS One; 2013; 8(4):e61436. PubMed ID: 23613852
[TBL] [Abstract][Full Text] [Related]
26. HIV-GRADE: a publicly available, rules-based drug resistance interpretation algorithm integrating bioinformatic knowledge.
Obermeier M; Pironti A; Berg T; Braun P; Däumer M; Eberle J; Ehret R; Kaiser R; Kleinkauf N; Korn K; Kücherer C; Müller H; Noah C; Stürmer M; Thielen A; Wolf E; Walter H
Intervirology; 2012; 55(2):102-7. PubMed ID: 22286877
[TBL] [Abstract][Full Text] [Related]
27. Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens.
Gonzalez de Requena D; Bonora S; Viganò O; Calcagno A; Cometto C; D'Avolio A; Baietto L; Ghisetti V; Magnani S; Ferramosca S; Vitiello P; Galli M; Rusconi S; Di Perri G
J Antimicrob Chemother; 2011 Jan; 66(1):192-200. PubMed ID: 21037251
[TBL] [Abstract][Full Text] [Related]
28. Genotypic resistance tests for the management of patients with viro-immunological discordant response to highly active antiretroviral therapy.
Moroni M
Scand J Infect Dis Suppl; 2003; 106():85-7. PubMed ID: 15000593
[TBL] [Abstract][Full Text] [Related]
29. Comparison of nine resistance interpretation systems for HIV-1 genotyping.
Stürmer M; Doerr HW; Staszewski S; Preiser W
Antivir Ther; 2003 Jun; 8(3):239-44. PubMed ID: 12924541
[TBL] [Abstract][Full Text] [Related]
30. The relationship between genotypic sensitivity score and treatment outcomes in late stage HIV disease after supervised HAART.
Castor D; Vlahov D; Hoover DR; Berkman A; Wu YF; Zeller B; Brechtl J; Hammer SM
J Med Virol; 2009 Aug; 81(8):1323-35. PubMed ID: 19551816
[TBL] [Abstract][Full Text] [Related]
31. Initiatives for developing and comparing genotype interpretation systems: external validation of existing systems for didanosine against virological response.
Assoumou L; Brun-Vézinet F; Cozzi-Lepri A; Kuritzkes D; Phillips A; Zolopa A; Degruttola V; Miller V; Costagliola D;
J Infect Dis; 2008 Aug; 198(4):470-80. PubMed ID: 18598191
[TBL] [Abstract][Full Text] [Related]
32. Fosamprenavir/ritonavir in advanced HIV disease (TRIAD): a randomized study of high-dose, dual-boosted or standard dose fosamprenavir/ritonavir in HIV-1-infected patients with antiretroviral resistance.
Molina JM; Ait-Khaled M; Rinaldi R; Penco G; Baril JG; Cauda R; Soriano V; Pialoux G; Wire MB; Lou Y; Givens N; Craig C; Nichols WG; Barbosa I; Yeo J;
J Antimicrob Chemother; 2009 Aug; 64(2):398-410. PubMed ID: 19515730
[TBL] [Abstract][Full Text] [Related]
33. Primary drug resistance in antiretroviral-naïve injection drug users.
Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
[TBL] [Abstract][Full Text] [Related]
34. Similar predictions of etravirine sensitivity regardless of genotypic testing method used: comparison of available scoring systems.
Vingerhoets J; Nijs S; Tambuyzer L; Hoogstoel A; Anderson D; Picchio G
Antivir Ther; 2012; 17(8):1571-9. PubMed ID: 22869341
[TBL] [Abstract][Full Text] [Related]
35. Extent of human immunodeficiency virus type 1 drug resistance as a predictor of virological failure after genotype-guided treatment switch.
Dionisio D; Vivarelli A; Zazzi M; Esperti F; Uberti M; Polidori M
Clin Infect Dis; 2001 Sep; 33(5):706-9. PubMed ID: 11486293
[TBL] [Abstract][Full Text] [Related]
36. Factors associated with virological success with raltegravir-containing regimens and prevalence of raltegravir-resistance-associated mutations at failure in the ARCA database.
Rusconi S; Vitiello P; Adorni F; Bruzzone B; De Luca A; Micheli V; Meraviglia P; Maserati R; Di Pietro M; Colao G; Penco G; Di Biagio A; Punzi G; Monno L; Zazzi M;
Clin Microbiol Infect; 2013 Oct; 19(10):936-42. PubMed ID: 23289841
[TBL] [Abstract][Full Text] [Related]
37. Evolution of antiretroviral prescription and response over a period of 8 years: an Italian multicentre observational prospective cohort study.
Sighinolfi L; Torti C; Zeni C; Ghinelli F; Suter F; Maggiolo F; Antinori A; Antonucci G; Castelnuovo F; Ladisa N; Migliorino M; Novati S; De Luca A; Lo Caputo S; Paraninfo G; Tinelli C; Carosi G;
Infection; 2008 Jun; 36(3):244-9. PubMed ID: 18454340
[TBL] [Abstract][Full Text] [Related]
38. Comparison between rules-based human immunodeficiency virus type 1 genotype interpretations and real or virtual phenotype: concordance analysis and correlation with clinical outcome in heavily treated patients.
Torti C; Quiros-Roldan E; Keulen W; Scudeller L; Lo Caputo S; Boucher C; Castelli F; Mazzotta F; Pierotti P; Been-Tiktak AM; Buccoliero G; De Gennaro M; Carosi G; Tinelli C;
J Infect Dis; 2003 Jul; 188(2):194-201. PubMed ID: 12854073
[TBL] [Abstract][Full Text] [Related]
39. Study of different systems for interpreting results of genotypic antiretroviral drug resistance tests.
García F; Palomares JC; Martínez NM; Alvarez M; Suarez S; García F; Rodríguez JM; Quero JH; del Carmen Maroto M
Antivir Ther; 2003 Jun; 8(3):251-2. PubMed ID: 12924543
[No Abstract] [Full Text] [Related]
40. Predicting response to antiretroviral treatment by machine learning: the EuResist project.
Zazzi M; Incardona F; Rosen-Zvi M; Prosperi M; Lengauer T; Altmann A; Sonnerborg A; Lavee T; Schülter E; Kaiser R
Intervirology; 2012; 55(2):123-7. PubMed ID: 22286881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
